<DOC>
	<DOC>NCT01333384</DOC>
	<brief_summary>The purpose of this study is to evaluate over the 24 month prospective follow up - in everyday clinical practice - resource utilization and effectiveness of the treatment of acromegalic patients in Poland with Somatuline Autogel 120 mg including extended injection intervals.</brief_summary>
	<brief_title>Study in Polish Acromegalic Patients Treated With Somatuline Autogel</brief_title>
	<detailed_description />
	<mesh_term>Acromegaly</mesh_term>
	<mesh_term>Lanreotide</mesh_term>
	<mesh_term>Angiopeptin</mesh_term>
	<criteria>Adult patients with acromegaly treated for at least three injections with Somatuline Autogel 120 mg Subjects must be treated for acromegaly for at least 1 year, with medical treatment prior to inclusion. One year historical data must be available Active participation in any interventional or any other noninterventional acromegaly clinical study. Previous participation in observational / postmarketing study of other somatostatin analogue should not be an exclusion criteria</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>